Adjunctive S-adenosylmethionine (SAMe) in treating non-remittent major depressive disorder: An 8-week double-blind, randomized, controlled trial
Version 2 2024-06-06, 08:37
Version 1 2018-10-01, 00:00
journal contribution
posted on 2024-06-06, 08:37 authored by J Sarris, GJ Byrne, C Bousman, C Stough, J Murphy, P MacDonald, L Adams, S Nazareth, G Oliver, L Cribb, K Savage, R Menon, S Chamoli, Michael BerkMichael Berk, C Ng, D MischoulonAdjunctive S-adenosylmethionine (SAMe) in treating non-remittent major depressive disorder: An 8-week double-blind, randomized, controlled trial
History
Related Materials
- 1.
Location
NetherlandsLanguage
EnglishPublication classification
C1 Refereed article in a scholarly journalCopyright notice
2018, ElsevierJournal
European NeuropsychopharmacologyVolume
28Pagination
1126-1136ISSN
0924-977XeISSN
1873-7862Issue
10Publisher
ELSEVIER SCIENCE BVUsage metrics
Categories
No categories selectedKeywords
Science & TechnologyLife Sciences & BiomedicineClinical NeurologyNeurosciencesPharmacology & PharmacyPsychiatryNeurosciences & NeurologySAMeAntidepressantNutraceuticalDepressionClinical trialPLACEBO-RESPONSE RATESADENOSYL METHIONINECLINICAL-TRIALPOLYMORPHISMMETAANALYSISASSOCIATIONRELIABILITYVALIDITYBETA110999 Neurosciences not elsewhere classified920410 Mental HealthFaculty of HealthSchool of MedicineInstitute for Innovation in Mental and Physical Health and Clinical Translation3209 Neurosciences3202 Clinical sciences420313 Mental health services200409 Mental health
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC